CGON
Price
$24.95
Change
-$0.95 (-3.67%)
Updated
Jul 15 closing price
Capitalization
1.9B
22 days until earnings call
MREO
Price
$1.71
Change
-$0.01 (-0.58%)
Updated
Jul 15 closing price
Capitalization
271.89M
83 days until earnings call
Interact to see
Advertisement

CGON vs MREO

Header iconCGON vs MREO Comparison
Open Charts CGON vs MREOBanner chart's image
CG Oncology
Price$24.95
Change-$0.95 (-3.67%)
Volume$703.05K
Capitalization1.9B
Mereo BioPharma Group
Price$1.71
Change-$0.01 (-0.58%)
Volume$2.68M
Capitalization271.89M
CGON vs MREO Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. MREO commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and MREO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (CGON: $24.95 vs. MREO: $1.71)
Brand notoriety: CGON and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 84% vs. MREO: 111%
Market capitalization -- CGON: $1.9B vs. MREO: $271.89M
CGON [@Biotechnology] is valued at $1.9B. MREO’s [@Biotechnology] market capitalization is $271.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileMREO’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • MREO’s FA Score: 0 green, 5 red.
According to our system of comparison, CGON is a better buy in the long-term than MREO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while MREO’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 4 bearish.
  • MREO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MREO is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -3.89% price change this week, while MREO (@Biotechnology) price change was -39.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

MREO is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.9B) has a higher market cap than MREO($272M). CGON YTD gains are higher at: -13.006 vs. MREO (-51.143). MREO has higher annual earnings (EBITDA): -44.87M vs. CGON (-134.35M). CGON has more cash in the bank: 688M vs. MREO (62.5M). MREO has less debt than CGON: MREO (747K) vs CGON (1.04M). CGON has higher revenues than MREO: CGON (662K) vs MREO (0).
CGONMREOCGON / MREO
Capitalization1.9B272M699%
EBITDA-134.35M-44.87M299%
Gain YTD-13.006-51.14325%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M62.5M1,101%
Total Debt1.04M747K139%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONMREO
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGOLF0.060.02
+45.68%
Thunder Gold Corp.
NJDCY4.570.02
+0.44%
Nidec Corp.
DTNOY12.48N/A
N/A
DNO ASA
TSPH0.28N/A
N/A
CreateAI Holdings Inc
AAFRF2.71-0.01
-0.55%
Airtel Africa Plc

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-3.67%
IDYA - CGON
62%
Loosely correlated
-5.09%
SYRE - CGON
59%
Loosely correlated
-6.70%
ACLX - CGON
58%
Loosely correlated
-2.53%
KYMR - CGON
56%
Loosely correlated
+0.02%
NUVL - CGON
55%
Loosely correlated
-1.94%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with RARE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-0.58%
RARE - MREO
66%
Loosely correlated
-6.94%
TRDA - MREO
46%
Loosely correlated
-6.32%
CGON - MREO
43%
Loosely correlated
-3.67%
TERN - MREO
41%
Loosely correlated
-1.17%
NRIX - MREO
40%
Loosely correlated
-4.26%
More